Teladoc Health, Inc. provided revenue guidance for the year ending December 31, 2021. For the period, the company expects total revenue to be approximately $2,030 million.
Market Closed -
Other stock markets
|
Pre-market 06:50:20 pm | |||
10.09 USD | +8.96% |
|
10.07 | -0.20% |
16/07 | Teladoc, Brightline to Offer Virtual Pediatric Mental Health Services | MT |
09/07 | Evercore ISI Lowers Price Target on Teladoc to $10 From $14, Maintains In Line Rating | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-53.18% | 1.71B | |
+159.66% | 4.96B | |
-9.45% | 390M | |
+8.04% | 353M | |
-31.08% | 81.27M |
- Stock Market
- Equities
- TDOC Stock
- News Teladoc Health, Inc.
- Teladoc Health, Inc. Provides Revenue Guidance for the Year Ending December 31, 2021